期刊
STEM CELL REPORTS
卷 6, 期 4, 页码 456-465出版社
CELL PRESS
DOI: 10.1016/j.stemcr.2016.02.006
关键词
-
资金
- UCLA Eli & Edythe Broad Center of Regenerative Medicine and Stem Cell Research Innovation Award
- NIH/NIDCR [R01DE016513]
Embryonic stem cell-derived mesenchymal stromal cells (MSCs; also known as mesenchymal stem cells) represent a promising source for bone regenerative medicine. Despite remarkable advances in stem cell biology, the molecular mechanism regulating differentiation of human embryonic stem cells (hESCs) into MSCs remains poorly understood. Here, we report that inhibition of I kappa B kinase (IKK)/nuclear factor kappa B (NF-kappa B) signaling enhances differentiation of hESCs into MSCs by expediting the loss of pluripotent markers and increasing the expression of MSC surface markers. In addition, a significantly higher quantity of MSCs was produced from hESCs with IKK/NF-kappa B suppression. These isolated MSCs displayed evident multipotency with capacity to terminally differentiate into osteoblasts, chondrocytes, and adipocytes in vitro and to form bone in vivo. Collectively, our data provide important insights into the role of NF-kappa B in mesenchymal lineage specification during hESC differentiation, suggesting that IKK inhibitors could be utilized as an adjuvant in generating MSCs for cell-mediated therapies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据